Regular Dental Visits: Influence on Health-Related Quality of Life in 1,607 Patients with Oral Squamous Cell Carcinoma

Spalthoff, Simon; Holtmann, Henrik; Krüskemper, Gertrud; Zimmerer, Rüdiger; Handschel, Jörg; Gellrich, Nils-Claudius; Jehn, Philipp

doi:https://doi.org/10.1155/2017/9638345

International Journal of Dentistry

On this page

Abstract Introduction Materials and Methods Results Discussion Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2017 | Article ID 9638345 | https://doi.org/10.1155/2017/9638345

Regular Dental Visits: Influence on Health-Related Quality of Life in 1,607 Patients with Oral Squamous Cell Carcinoma

Simon Spalthoff,¹Henrik Holtmann,²Gertrud Krüskemper,³Rüdiger Zimmerer,¹Jörg Handschel,²Nils-Claudius Gellrich,¹and Philipp Jehn¹

Academic Editor: Andreas Stavropoulos

Received05 Dec 2016

Accepted07 May 2017

Published30 May 2017

Abstract

Background. The incidence of oral squamous cell carcinoma (OSCC) is in the top 10 of all cancer entities. Regular oral examinations by dentists play an important role in oral cancer prevention. Methods. Patients with OSCC (,607) and physicians (,489) completed questionnaires during the DÖSAK Rehab Study. The psychosocial and functional factors collected in these questionnaires were assessed in the present study. We compared patients who visited their dentist at least once a year (group A) with those who visited their dentist less than once a year (group B). Results. Patients in group A had significantly better health-related quality of life after tumor treatment than patients in group B. Patients in group A also had a smaller tumor size and less lymph node metastasis and lost fewer teeth during the treatment. This resulted in better prosthetic rehabilitation and better psychological status after tumor treatment. Conclusions. Dentists play an important role in the early recognition of oral cancer. This study should encourage dentists to take a more active role in oral cancer prevention.

1. Introduction

The incidence of oral squamous cell carcinoma (OSCC) is within the top 10 of all cancer entities [1]. The use of tobacco and excessive alcohol consumption are estimated to account for about 90% of all OSCCs [2, 3]. In addition, a relationship with human papillomavirus (HPV) has been shown in a number of studies demonstrating DNA from HPV, particularly with oropharyngeal carcinoma. The possibility of sexual transmission has thus been raised [4]. There is also evidence that average and poor oral hygiene and inadequate dental status are independent risk factors for OSCC and oropharyngeal squamous cell carcinoma, irrespective of tobacco and alcohol consumption [5–7].

Despite the progress in both research and therapy, the overall 5-year survival rate of OSCC is approximately 50–60% and has not changed significantly in recent years [8]. Furthermore, survival and cure rates vary considerably for the different tumor stages (I–IV) [9]. Patients with stage I tumors have a good prognosis, with cure rates of approximately 80%, while patients with stage II tumors have lower cure rates of approximately 65%. Many patients with advanced tumor stages (III and IV) have 5-year survival rates of approximately 16–50% and cure rates of approximately 30%. With the presence of distant metastasis, survival duration decreases to approximately 4 months [1, 10]. Therefore, early detection of OSCC is the single most important factor that influences prognosis.

Late diagnosis results in not only higher use of healthcare resources but also lower survival rates, function, and quality of life (QOL) among survivors [11–14]. Also, the more specific health-related quality of life (HRQOL) significantly decreases with increasing tumor stage [15]. Dentists, oral hygienists, and other healthcare providers play an important role in oral cancer prevention, by providing oral examinations and detecting early oral cancers. Currently, there is insufficient evidence to recommend a cost-intensive OSCC screening program for the whole population. Therefore, many authors recommend a targeted population approach that includes screening high-risk patients, such as severe smokers or heavy drinkers, for OSCC. This could shift the stage at detection and reduce overall mortality [10, 16–18].

Many dentists are currently reluctant to tell their patients they are performing an oral mucosal examination and often try to avoid the word cancer. Therefore, patients are often unaware of the oral cancer screening and remain uninformed of the particular risks for developing oral cancer [19]. In this large multicenter study, we examined the relationship between regular dental visits and OSCC-related HRQOL. Our aim was to demonstrate that regular dental visits could identify cancer earlier (lower tumor stage) and therefore lead to a higher posttreatment HRQOL. This would emphasize the dentist’s role in oral cancer prevention, without the implementation of specialized screening programs, and could help dentists to recognize their valuable role in oral cancer prevention.

2. Materials and Methods

2.1. Data Source

The sample for analyses consisted of usable, retrospective data for 1,652 patients with OSCC who were treated at 38 hospitals in Germany, Austria, and Switzerland; these data were collected during the DÖSAK Rehab Study. Patients included were those who had been diagnosed with and undergone surgery for OSCC, with or without other adjuvant therapies, at least 6 months before completing the questionnaire. All participants in the DÖSAK Rehab Study provided informed consent, and the current study was approved by the institutional review board of the Ruhr-Universität Bochum. During the DÖSAK Rehab Study, the Bochum Questionnaire on Rehabilitation and a physician questionnaire (,489) were distributed, comprising 147 items in 7 categories: demographics, health behavior, course of disease before surgery, course of disease after surgery, postoperative care, and coping with disease [20].

2.2. Patient Questionnaire

The patients were asked about their condition and symptoms at three time points in their treatment process: before treatment (), immediately after the operation (), and at least 6 months after the surgical intervention (). We only used for our evaluation.

The patient questionnaire included a list of 19 impairments, which were identified by oral and maxillofacial surgeons as the cause of most symptoms for patients with head and neck cancer, as a result of either the disease itself or subsequent treatment; these included restricted movement of the shoulder/arm, mandible, and neck, as well as difficulties with ingestion and swallowing. The extent/severity of each of these impairments was rated using a five-level Likert scale (none, weak, medium, strong, and very strong).

In addition, more specific impairments were assessed via the patient questionnaire, such as the effects of scarring and swelling; pain in the oral cavity, the temporomandibular joint, and neck and shoulder region; and numb regions in the area of operative treatment or paralysis of the facial muscles.

Data on the psychological status of each patient were collected using short-form standardized tests, including the State-Trait Anxiety Inventory (STAI) for anxiety [21], the five-level depressive scale by von Zerssen (DS) for depressive state [22], and the Freiburg Questionnaire of Coping with Illness (FQCI) for illness processing [23].

The STAI measures relatively stable interindividual differences in the tendency to evaluate situations as threatening and to react with an increasing state-anxiety. The STAI, with its two subscales, was used to document both situation-specific and enduring anxiety. In the present study, the second scale (Trait) was particularly appropriate because of its temporal and situational independency (reliability). The DS measures the presence and, if necessary, the intensity of psychopathologic symptoms in terms of depressive, anxious, or nervous displeasure without giving a clear nosologic diagnosis. With its broad spectrum, the FQCI measures clinically relevant mechanisms of illness coping on cognitive, emotional, and actional levels.

The results for STAI, DS, and FQCI were classified for comparisons. We defined a cut-off point for each measurement (STAI 8/4, DS 8/4, and FKV 10/4); values below this point were classified as low or not pathological, and values above this point were classified as high or pathological.

2.3. Physician Questionnaire

The physician questionnaire provided an overview of medically relevant patient data, such as tumor location, tumor size, treatment and reconstructive technique, and type of lymphadenectomy. All surveyed patients were treated surgically.

2.4. Measurements and Evaluations

Patients were divided into two groups based on their regular dental visits. Group A visited their dentist ≥1 time per year, and group B visited their dentist <1 time per year.

Tumor size and lymph node status were classified according to the Union for International Cancer Control (UICC) classification for malignant tumors (1987).

QOL was measured on a scale of 0 to 100, where 0 is very bad and 100 is very good, based on the question “Estimate your own actual QOL on a scale of 0 to 100.” The responses for QOL after tumor therapy were divided into three groups: unsatisfied (0–50), rather satisfied (51–80), or very satisfied (81–100). The HRQOL in groups A and B was measured based on QOL and the 7 impairments that had the highest correlations with dental visits.

2.5. Statistical Analysis

Statistical analysis was performed using SPSS version 22 (IBM Corp., Armonk, NY, USA), including descriptive statistics, cross-tabulations with Pearson’s chi-square tests, and Kendall’s tau-b. In addition to the groups based on regular dental visits, we also divided the patients into two groups based on remaining teeth after tumor treatment: those with remaining teeth and those who were edentulous. A value < 0.05 was considered statistically significant.

3. Results

3.1. Patient Characteristics

Of the 1,652 patients (413 [25%] women, 1,239 [75%] men), 911 patients received surgical treatment only, 502 underwent additional radiotherapy, 78 received additional chemotherapy, 131 underwent additional radio/chemotherapy, and data were not available for 30 patients. Regarding age, 53 patients were ≤40 years old, 829 patients were 41–60 years old, 594 patients were 61–75 years old, and 114 patients were >75 years old.

3.2. Dental Visits

Information regarding dental visits was provided by 1,607 patients (Figure 1): 65% (,049) visited ≥1 time per year (group A), and 35% () visited <1 time per year (group B). Compared with group B, group A consisted of significantly more women than men, more white-collar workers () than blue-collar workers (), and more nonsmokers or nondrinkers (all, ). The frequency of dental visits did not differ by age.

3.3. Tumor Size and Lymph Node Status

Tumor size was significantly larger, and lymph node metastasis was present significantly more often in group B than in group A ( for tumor size and for lymph node metastasis, Table 1).

3.4. Tooth Loss and Prosthetic Rehabilitation

Patients in group B lost 10 teeth throughout the tumor treatment significantly more often and were edentulous significantly more often than the patients in group A (both , Table 2). Edentulous patients experienced postoperative impairment significantly more often, including numb regions in the lower lip and chin region (), paresis at the corner of the mouth (), and uncontrollable salivation at the angle of the mouth (). Patients in group A could be rehabilitated with a partial prosthesis in the upper and lower jaws significantly more often than patients in group B ().

3.5. Quality of Life and Health-Related Quality of Life

The HRQOL in groups A and B was measured based on QOL and the 7 impairments that had the highest correlations with dental visits: shoulder-arm-mobility (correlation coefficient [CC] 0.073), speech intelligibility for foreigners (CC 0.069), tongue mobility (CC 0.065), speech intelligibility for relatives (CC 0.058), mouth aperture (CC 0.047), mandible mobility (CC 0.047), and eating/swallowing (CC 0.049). General HRQOL (including impairments in speech, eating/swallowing, opening of mouth, shoulder/arm movement, general condition, breathing, and appearance) was significantly lower in group B than in group A (). Patients with remaining teeth described significantly fewer impairments after treatment than edentulous patients (Table 3). In addition, patients who required rehabilitation with a full prosthesis in either jaw reported significantly lower HRQOL than people with a partial prosthesis ().

3.6. Social and Psychological Status

Significantly more patients in group B experienced fear (), depressive tendency (), and depressive illness coping (). In addition, patients in group B rated their public appearance significantly lower after treatment (), and significantly fewer patients in group B were able to return to work in their former job than patients in group A ().

4. Discussion

The treatment modality, age, and sex distributions in the present study were comparable to those in other studies of OSCC [24–26]. Similar to previous studies, more educated people (white-collar workers) visited their dentist more frequently than less educated people (blue-collar workers) [27, 28]. The return to work by more patients in group A might be related to the association between a higher socioeconomic status and regular dental visits as well as resumption of work after tumor treatment [29, 30].

In contrast to the findings of previous studies, women visited their dentist more often than men [31], and there was no age difference in DV [32, 33]. Nonsmokers and nondrinkers visited their dentist more often, similar to previous studies [34–37]. Tumor size and lymph node status were significantly lower in group A, indicating that patients who regularly visit their dentist are treated at a lower tumor stage, as reported previously [14, 38, 39]. However, it is currently unknown if this results in lower mortality rates or improved survival rates across the population; only one high-quality randomized controlled trial supports this theory [16, 40]. Therefore, many authors agree that it is more important to screen high-risk patients, such as heavy smokers and drinkers, on a regular basis than to perform an opportunistic screening of the whole population [18, 31].

Regarding HRQOL after tumor therapy, HRQOL was significantly higher and psychological status was significantly better in group A, indicating a link between the frequency of dental visits and HRQOL. A link between depressive symptoms and oral health has also been suggested [41]. Patients visiting their dentist on a regular basis lost significantly less teeth during tumor treatment, and fewer of these patients were edentulous after treatment. Therefore, dental rehabilitation with a partial prosthesis was possible. Edentulous patients wearing a full prosthesis had a significantly lower overall QOL than the patients in group A, supporting the findings of Rogers [42]. Even HRQOL was significantly lower in group B; more of these patients complained about numb regions in the lower lip and chin region, paresis of the corner of the mouth, and uncontrollable salivation at the angle of the mouth. The relationship between tooth loss and HRQOL has been reported in a number of studies; even without the presence of a malignant tumor, tooth loss leads to a significant reduction in HRQOL [43, 44].

In our opinion, the better posttreatment dental situation of patients visiting their dentist on a regular basis is related to a lower tumor stage overall at the beginning of tumor therapy as well as better oral health. Therefore, excessive dentoalveolar surgical treatment was not required prior to tumor resection, which normally includes the operative removal of teeth with caries in patients with malignant tumors [45–47].

In conclusion, there are two main benefits of regular dental visits for patients with OSCC: reduced tumor stage and better oral health at the primary presentation. These two benefits result in better posttreatment HRQOL and psychological status in these patients. Therefore, we strongly recommend dental visits at least once a year as opportunistic screening; although mortality rates might not be reduced, HRQOL could be significantly improved for these patients after treatment of OSCC. This should encourage every dentist to perform opportunistic cancer screening and to inform their patients about the obvious benefits of regular dental visits for oral cancer.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

The authors would like to thank the DÖSAK and all of the staff from the participating Clinics of Oral and Maxillofacial Surgery: Basel, Berlin (Steglitz), Berlin (Virchow), Bochum, Bonn, Dortmund, Duisburg, Düsseldorf, Erfurt, Erlangen, Essen, Frankfurt, Freiburg, Greifswald, Halle, Hannover, Heidelberg, Homburg-Saar, Innsbruck, Kiel, Cologne, Krefeld, Linz, Lübeck, Mainz, Marburg, Munich (LMU), Münster, Osnabrück, Recklinghausen, Regensburg, Rostock, Saarbrücken, Siegen, Suhl, Ulm, Würzburg, and Zürich. With their patients, these staff members collected the valuable data for this study.

References

C. Rivera, “Essentials of oral cancer,” Int J Clin Exp Pathol, vol. 8, pp. 11884–11894, 2015.
View at: Google Scholar
W. L. Dissanayaka, G. Pitiyage, P. V. R. Kumarasiri, R. L. P. R. Liyanage, K. D. Dias, and W. M. Tilakaratne, “Clinical and histopathologic parameters in survival of oral squamous cell carcinoma,” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, vol. 113, no. 4, pp. 518–525, 2012.
View at: Publisher Site | Google Scholar
L. A. Moreno-López, G. C. Esparza-Gómez, A. González-Navarro, R. Cerero-Lapiedra, M. J. González-Hernández, and V. Domínguez-Rojas, “Risk of oral cancer associated with tobacco smoking, alcohol consumption and oral hygiene: a case-control study in Madrid, Spain,” Oral Oncology, vol. 36, no. 2, pp. 170–174, 2000.
View at: Publisher Site | Google Scholar
C. Scully and J. Bagan, “Oral squamous cell carcinoma overview,” Oral Oncology, vol. 45, no. 4-5, pp. 301–308, 2009.
View at: Publisher Site | Google Scholar
T. V. Narayan, G. M. Revanna, U. Hallikeri, and M. A. Kuriakose, “Dental Caries and Periodontal Disease Status in Patients with Oral Squamous Cell Carcinoma: A Screening Study in Urban and Semiurban Population of Karnataka,” Journal of Maxillofacial and Oral Surgery, vol. 13, no. 4, pp. 435–443, 2014.
View at: Publisher Site | Google Scholar
K. Rosenquist, J. Wennerberg, E.-B. Schildt, A. Bladström, B. Göran Hansson, and G. Andersson, “Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden,” Acta Oto-Laryngologica, vol. 125, no. 12, pp. 1327–1336, 2005.
View at: Publisher Site | Google Scholar
M. Tezal, M. A. Sullivan, A. Hyland et al., “Chronic periodontitis and the incidence of head and neck squamous cell carcinoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 9, pp. 2406–2412, 2009.
View at: Publisher Site | Google Scholar
S. N. Rogers, J. S. Brown, J. A. Woolgar et al., “Survival following primary surgery for oral cancer,” Oral Oncology, vol. 45, no. 3, pp. 201–211, 2009.
View at: Publisher Site | Google Scholar
S. G. Patel and J. P. Shah, “TNM staging of cancers of the head and neck: striving for uniformity among diversity,” Ca-A Cancer Journal for Clinicians, vol. 55, no. 4, pp. 242–264, 2005.
View at: Publisher Site | Google Scholar
D. V. Messadi, P. Wilder-Smith, and L. Wolinsky, “Improving oral cancer survival: the role of dental providers,” Journal of the California Dental Association, vol. 37, no. 11, pp. 789–798, 2009.
View at: Google Scholar
A. Chandu, K. C. V. Sun, R. N. DeSilva, and A. C. H. Smith, “The assessment of quality of life in patients who have undergone surgery for oral cancer: a preliminary report,” Journal of Oral and Maxillofacial Surgery, vol. 63, no. 11, pp. 1606–1612, 2005.
View at: Publisher Site | Google Scholar
M. D. Mignogna, S. Fedele, L. Lo Russo, E. Ruoppo, and L. Lo Muzio, “Costs and effectiveness in the care of patients with oral and pharyngeal cancer: Analysis of a paradox,” European Journal of Cancer Prevention, vol. 11, no. 3, pp. 205–208, 2002.
View at: Publisher Site | Google Scholar
H. Schliephake and M. U. Jamil, “Prospective evaluation of quality of life after oncologic surgery for oral cancer,” International Journal of Oral and Maxillofacial Surgery, vol. 31, no. 4, pp. 427–433, 2002.
View at: Publisher Site | Google Scholar
J. M. Watson, H. L. Logan, S. L. Tomar, and P. Sandow, “Factors associated with early-stage diagnosis of oral and pharyngeal cancer,” Community Dentistry and Oral Epidemiology, vol. 37, no. 4, pp. 333–341, 2009.
View at: Publisher Site | Google Scholar
A. Chandu, A. C. H. Smith, and S. N. Rogers, “Health-related quality of life in oral cancer: A review,” Journal of Oral and Maxillofacial Surgery, vol. 64, no. 3, pp. 495–502, 2006.
View at: Publisher Site | Google Scholar
P. Brocklehurst, O. Kujan, L. A. O’Malley, G. Ogden, S. Shepherd, and A.-M. Glenny, “Screening programmes for the early detection and prevention of oral cancer,” Cochrane database of systematic reviews, vol. 11, article CD004150, 2013.
View at: Google Scholar
M. McGurk and S. E. Scott, “The reality of identifying early oral cancer in the general dental practice,” British Dental Journal, vol. 208, no. 8, pp. 347–351, 2010.
View at: Publisher Site | Google Scholar
I. van der Waal, R. de Bree, R. Brakenhoff, and J.-W. Coebergh, “Early diagnosis in primary oral cancer: is it possible?” Medicina Oral, Patologia Oral y Cirugia Bucal, vol. 16, no. 3, pp. e300–e305, 2011.
View at: Publisher Site | Google Scholar
O. Awojobi, S. E. Scott, and T. Newton, “Patients’ perceptions of oral cancer screening in dental practice: a cross-sectional study,” BMC Oral Health, vol. 12, no. 1, article 55, 2012.
View at: Publisher Site | Google Scholar
N.-C. Gellrich, M. M. Suarez-Cunqueiro, A. Bremerich, and A. Schramm, “Characteristics of oral cancer in a central European population: Defining the dentist's role,” Journal of the American Dental Association, vol. 134, no. 3, pp. 307–314, 2003.
View at: Publisher Site | Google Scholar
G. Laux, “Study on anxiety during dental treatment,” ZWR, vol. 81, no. 22, pp. 1078–1080, 1972.
View at: Google Scholar
D. Zerssen, “Typus melancholicus from a psychometric viewpoint (part 1),” Z Klin Psychol Psychother, vol. 24, no. 3, pp. 200–220, 1976.
View at: Google Scholar
F. A. Muthny, “References for evaluation scales in quality assurance in rehabilitation—6. Assessment of coping processes with the Freiburg Questionnaire of Illness Coping,” Rehabilitation (Stuttg), vol. 35, no. 2, pp. IX–XVI, 1996.
View at: Google Scholar
F. P. de Andrade, M. G. H. Biazevic, T. N. Toporcov, J. Togni, M. B. de Carvalho, and J. L. F. Antunes, “Discriminant validity of the University of Washington quality of life questionnaire in the Brazilian context,” Revista Brasileira de Epidemiologia, vol. 15, no. 4, pp. 781–789, 2012.
View at: Publisher Site | Google Scholar
M. Rana, N.-C. Gellrich, and M. Rana, “Comparison of health-related quality of life of patients with different precancer and oral cancer stages,” Clinical Oral Investigations, vol. 19, no. 2, pp. 481–488, 2015.
View at: Publisher Site | Google Scholar
F. Stelzle, C. Knipfer, M. Schuster et al., “Factors influencing relative speech intelligibility in patients with oral squamous cell carcinoma: A prospective study using automatic, computer-based speech analysis,” International Journal of Oral and Maxillofacial Surgery, vol. 42, no. 11, pp. 1377–1384, 2013.
View at: Publisher Site | Google Scholar
C. Masseria and M. Giannoni, “Equity in access to health care in Italy: A disease-based approach,” European Journal of Public Health, vol. 20, no. 5, pp. 504–510, 2010.
View at: Publisher Site | Google Scholar
E. van Doorslaer, X. Koolman, and A. M. Jones, “Explaining income-related inequalities in doctor utilisation in Europe,” Health Economics, vol. 13, no. 7, pp. 629–647, 2004.
View at: Publisher Site | Google Scholar
L. M. Jamieson and W. M. Thomson, “Adult oral health inequalities described using area-based and household-based socioeconomic status measures,” Journal of Public Health Dentistry, vol. 66, no. 2, pp. 104–109, 2006.
View at: Publisher Site | Google Scholar
J.-H. Park, J.-H. Park, S.-G. Kim, K.-S. Lee, and M.-I. Hahm, “Changes in employment status and experience of discrimination among cancer patients: findings from a nationwide survey in Korea,” Psycho-Oncology, vol. 19, no. 12, pp. 1303–1312, 2010.
View at: Publisher Site | Google Scholar
A. M. Frydrych and L. M. Slack-Smith, “Dental attendance of oral and oropharyngeal cancer patients in a public hospital in Western Australia,” Australian Dental Journal, vol. 56, no. 3, pp. 278–283, 2011.
View at: Publisher Site | Google Scholar
A. N. Åstrøm, G. Ekback, S. Ordell, and E. Nasir, “Long-term routine dental attendance: Influence on tooth loss and oral health-related quality of life in Swedish older adults,” Community Dentistry and Oral Epidemiology, vol. 42, no. 5, pp. 460–469, 2014.
View at: Publisher Site | Google Scholar
V. Pohjola, S. Lahti, M. Tolvanen, and H. Hausen, “Dental fear and oral health habits among adults in Finland,” Acta Odontologica Scandinavica, vol. 66, no. 3, pp. 148–153, 2008.
View at: Publisher Site | Google Scholar
B. Bloom, P. F. Adams, R. A. Cohen, and C. Simile, “Smoking and oral health in dentate adults aged 18–64,” NCHS data brief, no. 85, pp. 1–8, 2012.
View at: Google Scholar
J. Csikar, J. Kang, C. Wyborn, T. A. Dyer, Z. Marshman, and J. Godson, “The self-reported oral health status and dental attendance of smokers and non-smokers in England,” PLoS ONE, vol. 11, no. 2, Article ID e0148700, 2016.
View at: Publisher Site | Google Scholar
L. Hellqvist, M. Rolandsson, D. Birkhed, and A. Hugoson, “Tobacco use in relation to socioeconomic factors and dental care habits among swedish individuals 15–70 years of age, 1983–2003,” International Journal of Dental Hygiene, vol. 7, no. 1, pp. 62–70, 2009.
View at: Publisher Site | Google Scholar
E. Bernabé, M. Kivimäki, G. Tsakos et al., “The relationship among sense of coherence, socio-economic status, and oral health-related behaviours among Finnish dentate adults,” European Journal of Oral Sciences, vol. 117, no. 4, pp. 413–418, 2009.
View at: Publisher Site | Google Scholar
J. D. Holmes, E. J. Dierks, L. D. Homer, and B. E. Potter, “Is detection of oral and oropharyngeal squamous cancer by a dental health care provider associated with a lower stage at diagnosis?” Journal of Oral and Maxillofacial Surgery, vol. 61, no. 3, pp. 285–291, 2003.
View at: Publisher Site | Google Scholar
S. Warnakulasuriya, N. Fennell, P. Diz et al., “An appraisal of oral cancer and pre-cancer screening programmes in Europe: a systematic review,” Journal of Oral Pathology and Medicine, vol. 44, no. 8, pp. 559–570, 2015.
View at: Publisher Site | Google Scholar
R. Sankaranarayanan, K. Ramadas, G. Thomas et al., “Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial,” The Lancet, vol. 365, no. 9475, pp. 1927–1933, 2005.
View at: Publisher Site | Google Scholar
S. S. Anttila, M. L. E. Knuuttila, and T. K. Sakki, “Relationship of depressive symptoms to edentulousness, dental health, and dental health behavior,” Acta Odontologica Scandinavica, vol. 59, no. 6, pp. 406–412, 2001.
View at: Publisher Site | Google Scholar
S. N. Rogers, “Quality of life for head and neck cancer patients—has treatment planning altered?” Oral Oncology, vol. 45, no. 4-5, pp. 435–439, 2009.
View at: Publisher Site | Google Scholar
C. Cano-Gutiérrez, M. G. Borda, A. J. Arciniegas, and C. X. Borda, “Edentulism and dental prostheses in the elderly: impact on quality of life measured with EuroQol - visual analog scale (EQ-VAS),” Acta Odontol Latinoam, vol. 28, pp. 149–155, 2015.
View at: Google Scholar
M. V. D. L. Saintrain and E. H. A. De Souza, “Impact of tooth loss on the quality of life,” Gerodontology, vol. 29, no. 2, pp. e632–e636, 2012.
View at: Publisher Site | Google Scholar
K. Bertl, S. Loidl, U. Kotowski et al., “Oral health status and dental care behaviours of head and neck cancer patients: a cross-sectional study in an Austrian tertiary hospital,” Clinical Oral Investigations, vol. 20, no. 6, pp. 1317–1327, 2016.
View at: Publisher Site | Google Scholar
S. Moore, M. C. Burke, M. R. Fenlon, and A. Banerjee, “The role of the general dental practitioner in managing the oral care of head and neck oncology patients,” Dental Update, vol. 39, no. 10, pp. 694–702, 2012.
View at: Google Scholar
S. Silverman Jr., “Oral cancer: complications of therapy,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, vol. 88, no. 2, pp. 122–126, 1999.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2017 Simon Spalthoff et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1901

Downloads

1057

Citations